Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors
- PMID: 17720018
- DOI: 10.1016/S0140-6736(07)61343-9
Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors
Abstract
Background: Individuals with diabetes are at higher risk of myocardial infarction than non-diabetics. However, much less is known about the incidence of, and risk factors for, development of diabetes and impaired fasting glucose in patients who have had a myocardial infarction. We set out to estimate this incidence and investigate whether lifestyle factors such as dietary habits might alter this risk.
Methods: We used prospectively obtained data for 8291 Italian patients with a myocardial infarction within the previous 3 months, who were free of diabetes (determined by medication use, a physician-reported diagnosis, or fasting glucose > or =7 mmol/L) at baseline. Incidence of new-onset diabetes (new diabetes medication or fasting glucose > or =7 mmol/L) and impaired fasting glucose (fasting glucose > or =6.1 mmol/L and <7 mmol/L) were assessed at follow-up at 0.5, 1.0, 1.5, 2.5, and 3.5 years. Baseline data for body-mass index (BMI), other risk factors, dietary habits, and medications were updated during follow-up. A Mediterranean diet score was assigned according to consumption of cooked and raw vegetables, fruit, fish, and olive oil. Associations of demographic, clinical, and lifestyle risk-factors with incidence of diabetes and impaired fasting glucose were assessed with multivariable Cox proportional hazards.
Findings: During 26 795 person-years (mean follow-up 3.2 years [SD 0.9]), 998 individuals (12%) developed new-onset diabetes (incidence 37 cases per 1000 person-years). Of the 7533 without impaired fasting glucose at baseline, 2514 (33%) developed new-onset impaired fasting glucose or diabetes (incidence 123 cases per 1000 person-years), rising to 3859 (62%) of 6229 with the lower cutoff for impaired fasting glucose of 5.6 mmol/L (incidence 321 cases per 1000 person-years). Independent risk factors for new-onset diabetes or impaired fasting glucose included older age, hypertension, use of beta-blockers, lipid-lowering medications (protective), and diuretic use. Independent lifestyle risk-factors included higher BMI, greater BMI gain during follow-up, current smoking, a lower Mediterranean dietary score, and wine consumption of more than 1 L/day. Data for physical activity were unavailable, but inability to perform exercise testing was associated with higher incidence of diabetes and impaired fasting glucose.
Interpretation: Compared with population-based cohorts, patients with a recent myocardial infarction had a higher annual incidence rate of impaired fasting glucose (1.8 vs 27.5% in our study) and diabetes (0.8-1.6% compared with 3.7%) in this study. Thus, our results indicate that myocardial infarction could be a prediabetes risk equivalent. Smoking cessation, prevention of weight gain, and consumption of typical Mediterranean foods might lower this risk, which emphasises the need for guidance on diet and other lifestyle factors for patients who have had a myocardial infarction.
Comment in
-
Acute myocardial infarction and diabetes.Lancet. 2007 Aug 25;370(9588):634-5. doi: 10.1016/S0140-6736(07)61316-6. Lancet. 2007. PMID: 17719997 No abstract available.
Similar articles
-
Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.Diabet Med. 2012 Mar;29(3):399-403. doi: 10.1111/j.1464-5491.2011.03420.x. Diabet Med. 2012. PMID: 21883429
-
[The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance].Przegl Lek. 2007;64(6):410-5. Przegl Lek. 2007. PMID: 18159849 Clinical Trial. Polish.
-
Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.Circulation. 2004 May 11;109(18):2197-202. doi: 10.1161/01.CIR.0000126824.12785.B6. Epub 2004 May 3. Circulation. 2004. PMID: 15123532 Clinical Trial.
-
[Prevention of type 2 diabetes: a new public health challenge].Rev Med Liege. 2005 May-Jun;60(5-6):383-90. Rev Med Liege. 2005. PMID: 16035298 Review. French.
-
Healthy diet and lifestyle clustering and glucose intolerance.Proc Nutr Soc. 2002 Nov;61(4):543-51. doi: 10.1079/pns2002196. Proc Nutr Soc. 2002. PMID: 12691184 Review.
Cited by
-
Cardiometabolic medicine: time to recognize a new clinical specialty?Cardiovasc Endocrinol Metab. 2019 Jun;8(2):47-48. doi: 10.1097/XCE.0000000000000173. Epub 2019 May 15. Cardiovasc Endocrinol Metab. 2019. PMID: 31588426 Free PMC article. No abstract available.
-
Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.Curr Atheroscler Rep. 2008 Apr;10(2):106-16. doi: 10.1007/s11883-008-0016-0. Curr Atheroscler Rep. 2008. PMID: 18417064
-
Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national cohort study.Diabetes Care. 2013 Oct;36(10):3027-32. doi: 10.2337/dc12-2148. Epub 2013 May 30. Diabetes Care. 2013. PMID: 23723355 Free PMC article.
-
A moderate dosage of coffee causes acute retinal capillary perfusion decrease in healthy young individuals.BMC Ophthalmol. 2022 Nov 30;22(1):460. doi: 10.1186/s12886-022-02638-x. BMC Ophthalmol. 2022. PMID: 36451130 Free PMC article. Clinical Trial.
-
Comparison between QT Interval Parameters in Type 2 Diabetic and Nondiabetic Patients with Non-ST Elevation Myocardial Infarction.J Tehran Heart Cent. 2014;9(4):166-73. Epub 2014 Jul 6. J Tehran Heart Cent. 2014. PMID: 25870641 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical